Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib

In the past decade, molecular-targeted drugs have been focused upon for the treatment of cancer. In 2002, gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor became available in Japan for the treatment of non-small cell lung cancer (NSCLC). Over 80% of selected patients,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Araki, Takuya, Yashima, Hideaki, Shimizu, Kimihiro, Aomori, Tohru, Hashita, Tadahiro, Kaira, Kyoichi, Nakamura, Tomonori, Yamamoto, Koujirou
Médium: Artigo
Jazyk:Inglês
Vydáno: Libertas Academica 2012
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3520446/
https://ncbi.nlm.nih.gov/pubmed/23239933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S7340
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky